Aurinia Pharmaceuticals (AUPH) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Aurinia Pharmaceuticals (AUPH) over the last 6 years, with Q3 2025 value amounting to $14.6 million.
- Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization rose 1.37% to $14.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 1.37%. This contributed to the annual value of $19.4 million for FY2024, which is 6695.29% up from last year.
- As of Q3 2025, Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization stood at $14.6 million, which was up 1.37% from $9.7 million recorded in Q2 2025.
- Aurinia Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $19.4 million for Q4 2024, and its period low was $346000.0 during Q1 2021.
- Over the past 5 years, Aurinia Pharmaceuticals' median Accumulated Depreciation & Amortization value was $2.7 million (recorded in 2022), while the average stood at $5.5 million.
- As far as peak fluctuations go, Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization plummeted by 199.2% in 2022, and later surged by 73141.39% in 2024.
- Aurinia Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $2.8 million in 2021, then decreased by 1.99% to $2.7 million in 2022, then skyrocketed by 330.41% to $11.6 million in 2023, then skyrocketed by 66.95% to $19.4 million in 2024, then decreased by 24.99% to $14.6 million in 2025.
- Its Accumulated Depreciation & Amortization stands at $14.6 million for Q3 2025, versus $9.7 million for Q2 2025 and $4.9 million for Q1 2025.